Clinical Trial

A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Name: A Study of HS-10506 in Chinese Patients With Insomnia Disorder — clinical trial record (NCT07587385)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary purpose of this phase 3 study is to evaluate the safety and the efficacy of HS-10506 (change versus placebo) on latency to persistent sleep (LPS) and wakefulness after sleep onset (WASO) measured by polysomnography (PSG) in Chinese adult participants with insomnia disorder.

Trial Details

NCT Number	NCT07587385
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Insomnia Disorder
Enrollment	732 participants
Start Date	2026-05-29
Primary Completion	2028-06-28 (estimated)
Study Completion	2028-08-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-14